When VOGX insiders can sell
Vogenx, Inc. · IPO prospectus filed 2026-08-12 · Single cliff · 180-day lock-up
That is the calendar date the clause computes to, counted from the prospectus date. It is the only date computable without knowing a future earnings date, which is why everything that could pull it earlier is printed below it on this page rather than folded into it.
How much stock, against how much trades
"Absorb days" is the shares coming free divided by average daily volume: how many full sessions of VOGX's entire turnover the release amounts to. It is a ratio, not a forecast — it does not know who wants to sell, and a founder with no intention of selling counts the same as a fund that has been waiting six months.
Exactly 7,667,587 shares, against 94,095 shares a day averaged over 20 sessions. Volume source: yahoo-finance2 daily bars (symbol not in our price table), through 2026-11-06. Dollar volume $1.6M a day. Middle third — no call.
Why there is no call on this deal
The numbers above are published, but no dated call was issued. A call only goes in the ledger when the expiry falls 15 to 45 days out, the prospectus states or implies a share count, and there are at least 20 sessions of volume — and the middle third of the cohort gets no call at all, because a call on every deal is not a call. Publishing one here would be padding the scoreboard with a coin flip.
The lock-up clause, in the issuer's words
Every other free lock-up calendar tells you 180 days and moves on. This is the actual sentence the date above was computed from, so that if the words do not support the number, the number is wrong and the filing is one click away.
However, subject to applicable securities law restrictions and excluding shares of restricted common stock that will remain unvested, these shares will be able to be sold in the public market beginning 180 days after the date of this prospectus. The lock-up agreements with the underwriters are expected to be subject to certain exceptions and the representatives of the underwriters may, in their sole discretion, release all or some portion of the shares subject to such lock-up agreements at any time and for any reason. See "Underwriting" for more information on expected lock-up agreements with the underwriters. Shares issued upon the exercise of stock options pursuant to future awards that may be granted under our equity incentive plans or pursuant to f…
Where the share count comes from
7,667,587 shares — derived: shares outstanding after the offering, less the shares sold in it. A count the prospectus prints and a count derived from two of its other numbers are not the same quality of claim, so which one this is gets said rather than implied.
| Shares outstanding after the offering | 13,917,587 |
| Shares sold in the offering | 6,250,000 |
| Locked up, coming free at expiry | 7,667,587 |
Shares of our common stock to be outstanding after this offering 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full). Use of proceeds We estimate that the net proceeds to us from the sale of 6,250,000 shares of our common stock in this offering will be approximately $73.6 million, or $84.9 million if the underwriters exercise their option to purchase additional shares in full, based on the initial public offering price of $13.00 per share, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.
Exceptions written into the lock-up (5)
Each of these is a route by which VOGX shares can move before 2027-02-08. The 10b5-1 carve-out is the one worth reading twice: it lets insiders put a selling plan in place during the lock-up, so the first sales can be automatic and immediate rather than discretionary and later.
- 10b5-1 plan
- bona fide gift or charitable transfer
- estate planning or family transfer
- option exercise or RSU settlement
- underwriter discretionary release
…ock or warrant received upon such conversion would be subject to restrictions similar to those in the immediately preceding paragraph; (c) the establishment or modification by lock-up parties of trading plans under Rule 10b5-1 under the Exchange Act for the transfer of lock-up securities, provided that such plans do not provide for the transfer of lock-up securities during the restricted period; or (d) the sale of our common stock pursuant to the terms of the underwriting agreement. Jones, in its sole discretion, may release the securities subject to any of the lock-up agreements to be entered with the underwriters as described above, in whole or in part at any time.
…ntained in the lock-up agreements between the underwriters and the lock-up parties do not apply, subject in certain cases to various conditions, to certain transactions, including transfers of lock-up securities: (i) as bona fide gifts, as a charitable contribution, or for bona fide estate planning purposes, (ii) by will or intestacy or any other testamentary document, (iii) to any trust for the direct or indirect benefit of the lock-up party or its immediate family, or if the lock-up party is a trust, to a trustor, trustee (or co-trustee) or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes here…
…nclude doctors, dentists, optometrists, podiatrists and chiropractors), certain other licensed healthcare professionals, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; federal government price reporting laws, which require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs; federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and analogous state and foreign laws and regulations, such as state and foreign…
…f our common stock based upon the initial public offering price per share of $13.00, each of which will occur immediately upon the closing of this offering, and excludes: 561,657 shares of common stock issuable upon the exercise of stock options outstanding as of March 31, 2026, with a weighted-average exercise price of $1.04 per share under our 2022 Equity Incentive Plan, or the 2022 Plan; 24,153 shares of common stock reserved for issuance under the 2022 Plan as of March 31, 2026, which shares will cease to be available for issuance at the time our 2026 Equity Incentive Plan, or the 2026 Plan, becomes effective; and 1,750,000 shar…
The lock-up agreements with the underwriters are expected to be subject to certain exceptions and the representatives of the underwriters may, in their sole discretion, release all or some portion of the shares subject to such lock-up agreements at any time and for any reason. See "Underwriting" for more information on expected lock-up agreements with the underwriters. Shares issued upon the exercise of stock options pursuant to future awards that may be granted under our equity incentive plans or pursuant to future awards granted under those plans wil…
How this reading of VOGX could be wrong
The lock-up period is restated 4 times in this prospectus. Issuers repeat the clause on the cover, in the summary, in the risk factors and in the underwriting section, and the wording is not always identical. The parser resolved them to one period; if a reader finds a restatement that disagrees, the quote above is the one it used.
The volume is a vendor's, not ours. VOGX is not in our own price table, so average daily volume comes from yahoo-finance2 daily bars (symbol not in our price table). Vendor bars for recently listed symbols are the ones most likely to be wrong.
Only 20 sessions of volume history. This is a recent IPO, and early volume is dominated by the offering itself. An average over 20 sessions of a stock that has barely traded is the weakest input on the page, and absorb days inherits every bit of that weakness.
The parser can misread a filing. That is why every number here is printed next to the words it came from. Earlier versions of this parser read the underwriters' 30-day over-allotment window as a 30-day lock-up on five deals, and double-counted one issuer's share total because the offering summary appears on both the cover and in the summary section.
Also unlocking in 2027-02 (4)
Lock-ups cluster, because IPOs cluster: these priced in the same window as VOGX and come free in the same month. Several heavy releases landing together is a different situation from one.
| Deal | Expiry | Shares free | Absorb days |
|---|---|---|---|
| ATTO Attovia Therapeutics, Inc. | 2027-02-01 | 26.0M | 76.2 sessions |
| BRVE Braveheart Bio, Inc. | 2027-02-02 | 51.9M | 139 sessions |
| LTGO Latigo Biotherapeutics, Inc. | 2027-02-03 | 44.0M | 193 sessions |
| BLSM BlossomHill Therapeutics, Inc. | 2027-02-03 | 21.3M | 137 sessions |
Learn to read these clauses yourself
The flow arithmetic on this page — shares unlocking divided by average daily volume, and why the clause has to be read rather than assumed — taught step by step, free.
Radar built 2026-11-07 from EDGAR full-text search over 424B4 filings · all 80 parsed lock-ups and the scoreboard · VOGX's prospectus on EDGAR · what funds carried these companies at before listing